Bioinformatics Solutions Inc

Name

Bioinformatics Solutions Inc

Legal name

Bioinformatics Solutions Inc.

Website

https://bioinfor.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Proteomics Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Proteomics & Mass Spectrometry Services (HLAGANAB), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

• Mass spectrometry software
• Proteomics data analysis
• Antibody sequencing software
• Glycoproteomics analysis
• Proteoform characterization

Headquarters

HQ city

Waterloo

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Software Licenses and Subscriptions: Revenue from selling and subscribing to software products including PEAKS Studio (desktop), PEAKS Online (server-based), PEAKS AB, PEAKS GlycanFinder, and ProteoformX. Subscription-based model with annual billing and perpetual license options.
2. Lab Services (CRO): Contract research organization services including DeepSuite offerings: DeepAB (antibody sequencing), DeepImmu (neoantigen discovery), DeepGlycan (glycan profiling), and DeepProteo (biomarker discovery). Project-based or service contract revenue.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Bioinformatics Solutions Inc (BSI) develops and sells AI-powered LC-MS/MS proteomics data analysis software under the PEAKS brand (PEAKS Studio, PEAKS Online, PEAKS AB, PEAKS GlycanFinder, ProteoformX) for peptide sequencing, database searching, PTM localization, and intact/top-down proteoform characterization. The company also provides fee-for-service proteomics laboratory services under the DeepSuite brand, including antibody sequencing, proteogenomics for neoantigen discovery, glycan profiling, and biomarker discovery for pharmaceutical, biotech, and academic customers.

Product overview

Bioinformatics Solutions Inc operates a comprehensive proteomics software platform centered around the PEAKS software family, complemented by CRO laboratory services under the DeepSuite brand. The core software portfolio includes PEAKS Studio (desktop discovery proteomics), PEAKS Online (server-based high-throughput multi-user proteomics), PEAKS AB (antibody/protein sequencing), PEAKS GlycanFinder (glycoproteomics/glycomics), and ProteoformX (top-down/intact proteomics). These are supported by modular components including DeepNovo (AI-powered de novo sequencing), PEAKS Q (quantification), and PEAKS IMS (ion mobility), as well as workflow components like Database Searching, DIA Workflow, Spectral Library Search, PTM Analysis, and Quality Control tools. The DeepSuite laboratory services (DeepAB, DeepImmu, DeepGlycan, DeepProteo) provide fee-for-service proteomics analysis. All products are powered by advanced AI algorithms and deep learning for accurate, real-time proteomics data analysis.

Differentiator

Problem solved

Functional benefit

Brands

• PEAKS Software: AI-powered LC-MS/MS proteomics software platform including PEAKS Studio, PEAKS Online, PEAKS AB, PEAKS GlycanFinder, and ProteoformX for proteomics data analysis
• DeepSuite

Products and services

• PEAKS Studio Complete desktop solution for bottom-up discovery and targeted proteomics, providing comprehensive LC-MS/MS data analysis with advanced de novo sequencing and database search capabilities for researchers and core labs.
• PEAKS Online High-throughput multi-user server-based discovery proteomics solution designed for collaborative research environments and large-scale proteomics projects.
• PEAKS AB Automated desktop solution for antibody and protein de novo sequencing, enabling rapid characterization of antibody sequences, CDRs, and modifications for biotherapeutic and research use.
• PEAKS GlycanFinder Sensitive and accurate solution for glycoproteomics and glycomics with structural resolution, supporting glycan identification and characterization workflows.
• ProteoformX Comprehensive proteoform characterization software combining intact mass profiling with top-down analysis to resolve full protein sequences, map modifications, and enable quantification, with CFR-compliance readiness for clinical and biopharmaceutical settings.
• DeepAB (lab service) Fee-for-service antibody sequencing, ADC analysis, PTM and glycan profiling by LC-MS performed by BSI's proteomics lab.
• DeepImmu (lab service) Integrated proteogenomics discovery pipeline service for neoantigen discovery supporting immunotherapy research.
• DeepGlycan (lab service) Glycan structure profiling service for purified proteins and complex lysate samples.
• DeepProteo (lab service) Advanced biomarker discovery and PTM profiling service for disease research.

Quantifiable outcome

• PEAKS Studio 13.1 featured in peer-reviewed paper demonstrating state-of-the-art proteomics performance on ZenoTOF 8600 platform
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Partnerships

Two partnerships are on record, tiered core and minor.

• SCIEXcoreTechnology or IntegrationSCIEX introduced BSI to clients for glycosylation analysis and Zeno TOF data handling. BSI's PEAKS software supports SCIEX instruments including ZenoTOF 8600 and handles latest ZT DIA scan formats. Strategic collaboration for proteomics data analysis on SCIEX platform.
• InfocomminorChannel Partner/ Reseller/ DistributorDistribution partner for regional market access, likely in Asian markets based on Infocom's presence as an IT/distribution company.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Protein Metrics (Dotmatics): Protein Metrics, now part of Dotmatics, sells biopharma protein characterization software (Byos, Byonic) directly competing with PEAKS Studio and PEAKS AB. It targets the same antibody, ADC, and biotherapeutic characterization use cases as BSI.
• Biognosys: Biognosys combines proteomics CRO services with the SpectroDive and Spectronaut software platforms, mirroring BSI's software-plus-service hybrid model. It is a leading vendor-neutral proteomics vendor serving pharma and academic customers globally.
• Genedata: Genedata provides enterprise scientific informatics for biopharma R&D, including proteomics data analysis and workflow management. It competes for the same large-pharma enterprise software budgets as BSI's PEAKS Online.

Broad incumbents

• Thermo Fisher Scientific (Proteome Discoverer): ThermoFisher is the dominant mass spectrometry instrument vendor and ships Proteome Discoverer, a direct competitor to PEAKS Studio. Its instrument-software bundling gives it privileged access to its installed base, a structural threat to vendor-neutral players like BSI.
• Bruker (BioPharma Compass): Bruker offers BioPharma Compass and timsMetabo for proteomics and biopharma characterization, bundled with its timsTOF instruments. It competes with PEAKS for proteoform and biotherapeutic workflows at the instrument-data interface.
• Dotmatics: Dotmatics is a broad scientific R&D informatics platform that acquired Protein Metrics and now offers end-to-end biologics characterization workflows. It overlaps with BSI's enterprise software motion at larger pharma customers.
• Schrödinger: Schrödinger is a computational chemistry and life sciences software platform that has expanded into biologics and predictive biology. While its primary focus is molecular simulation, it competes for biopharma R&D software budgets and increasingly for antibody/biologics workflows adjacent to BSI.

Emerging players

• Cell Signaling Technology: CST provides antibody-based proteomics services and reagents, including PTM profiling and pathway-focused mass spec workflows. It competes with BSI's DeepProteo and DeepGlycan services in disease-research-oriented proteomics projects.
• Promega: Promega offers proteomics reagents, services, and analytical tools that complement mass spectrometry workflows. It is a partial competitor in the proteomics services space and a potential distribution partner for BSI's CRO offerings.

Others

• SCIEX: SCIEX is BSI's core OEM partner for ZenoTOF data compatibility, but it also develops its own processing and quantitation software for its mass spectrometry instruments. It is both a channel partner and a latent competitive threat at the instrument-software boundary.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/peaksproteomics
• YouTubeyoutube.com/@bsi-peaks
• Facebookfacebook.com/bioinfor
• LinkedInlinkedin.com/company/bioinformatics-solutions-inc-

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioinformatics Solutions Inc